Caryopincaolide M, a rearranged abietane diterpenoid with new skeleton and a new iridoid from Caryopteris incana

doi:10.1007/s11418-018-1268-9

	Caryopincaolide M, a rearranged abietane diterpenoid with new skeleton and a new iridoid from Caryopteris incana
	Zhang, Cheng-Gang; Chen, Ting; Mao, Xu-Dong; Zhao, Sen-Miao; Chou, Gui-Xin
刊名	Journal of natural medicines
	2018-11-24
ISSN号	1861-0293
DOI	10.1007/s11418-018-1268-9
文献子类	Article
英文摘要	Caryopincaolide M (1), a new rearranged abietane diterpenoid with an unusual pent-4-enoic acid group on a 6/6/5 tricyclic ring system, and 7-epi-8-dehydroxypatriscabrol (3), a new iridoid, together with 17 known compounds, have been isolated from the whole plant of Caryopteris incana (Thunb.) Miq. Their structures were elucidated on the basis of 1-D and 2-D NMR, IR, and mass spectroscopic data. Compounds 1-5 were evaluated for their inhibitory activities against enzyme α-glucosidase, and the results showed that only 1 has moderate inhibitory activity against enzyme α-glucosidase with IC at 528.3 ± 12.37 mg/L.
语种	英语
内容类型	期刊论文
源URL	[http://119.78.100.183/handle/2S10ELR8/266437]
专题	中国科学院上海药物研究所
通讯作者	Chou, Gui-Xin
作者单位	The MOE Key Laboratory of Standardization of Chinese Medicines, and SATCM Key Laboratory of New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, China
推荐引用方式 GB/T 7714	Zhang, Cheng-Gang,Chen, Ting,Mao, Xu-Dong,et al. Caryopincaolide M, a rearranged abietane diterpenoid with new skeleton and a new iridoid from Caryopteris incana[J]. Journal of natural medicines,2018.
APA	Zhang, Cheng-Gang,Chen, Ting,Mao, Xu-Dong,Zhao, Sen-Miao,&Chou, Gui-Xin.(2018).Caryopincaolide M, a rearranged abietane diterpenoid with new skeleton and a new iridoid from Caryopteris incana.Journal of natural medicines.
MLA	Zhang, Cheng-Gang,et al."Caryopincaolide M, a rearranged abietane diterpenoid with new skeleton and a new iridoid from Caryopteris incana".Journal of natural medicines (2018).